Davita Inc Receivables Turnover Ratio (DVA), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Davita Inc   (NYSE: DVA)
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 

Davita Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Davita Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 4.76, this is below the company average, and notable indication of worsening business environment. Average collection period, for Davita Inc 's accounts receivable remained unchanged at 77 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 388 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 2674 to 2717.

What is Receivable Turnover Ratio?
What is Davita Inc Selling?


What is Receivable Turnover Ratio?





DVA Receivables Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Receivable Change 3.91 % 8.49 % 14.98 % 8.69 % 7.15 %
Y / Y Revenue Change 5.17 % 5.96 % 9.87 % 4.8 % 6.05 %
Receivable Turnover Ratio (TTM) 4.76 4.75 4.78 4.82 4.87
DVA's Total Ranking # 2717 # 2674 # 2534 # 2579 # 2402
Accounts Receivable average collection period days 77 77 76 76 75
Seq. Receivable Change 1.87 % 2.33 % 1.89 % -2.17 % 6.35 %
Seq. Revenue Change 4.06 % -5.64 % 5.83 % 1.2 % 4.84 %


Receivable Turnover Company Ranking
Within: No.
Healthcare Facilities Industry # 38
Healthcare Sector # 389
Overall Market # 2717

Receivable Turnover Ratio Statistics
High Average Low
18.06 6.28 4.47
(Dec. 31, 2006)   (March 31, 2009)






Financial Statements
Davita Inc 's Accounts Receivable $ 3,033 Millions Visit DVA's Balance sheet
Davita Inc 's Sales TTM $ 14,010 Millions Visit DVA's Income Statement
Sources of DVA's Revenues Visit DVA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Healthcare Facilities Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
DVA's Receivable Turnover Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
DVA's Growth Rates DVA's Roa DVA's Inventory Turnover Ratio DVA's Dividend Comparisons
DVA's Profitability Ratios DVA's Roi DVA's Asset Turnover Ratio DVA's Dividend Growth
DVA's Valuation Ratios DVA's Roe DVA's Financial Strength Ratios DVA's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Petvivo Holdings Inc   12.34 $ 1.182  Millions$ 0.096  Millions
Siga Technologies Inc  12.32 $ 53.659  Millions$ 4.356  Millions
Alpha Pro Tech Ltd   12.25 $ 62.204  Millions$ 5.077  Millions
Vivos Therapeutics Inc   12.21 $ 21.135  Millions$ 1.731  Millions
Milestone Scientific Inc   11.82 $ 8.855  Millions$ 0.749  Millions
Marpai Inc  11.71 $ 16.635  Millions$ 1.420  Millions
Catheter Precision Inc   11.62 $ 1.915  Millions$ 0.165  Millions
Icu Medical Inc  11.42 $ 2,159.998  Millions$ 189.166  Millions
National Healthcare Corp  11.40 $ 1,559.020  Millions$ 136.723  Millions
Nrc Health  11.35 $ 139.996  Millions$ 12.337  Millions
Picard Medical Inc   11.34 $ 5.983  Millions$ 0.528  Millions
Veracyte Inc   11.07 $ 544.735  Millions$ 49.194  Millions
International Stem Cell Corporation  10.91 $ 9.514  Millions$ 0.872  Millions
Premier Air Charter Holdings Inc   10.66 $ 31.562  Millions$ 2.961  Millions
C4 Therapeutics Inc   10.65 $ 35.039  Millions$ 3.290  Millions
Lifeloc Technologies Inc   10.48 $ 9.269  Millions$ 0.884  Millions
Irhythm Holdings Inc   10.32 $ 825.702  Millions$ 80.007  Millions
Immucell Corporation  10.29 $ 29.777  Millions$ 2.893  Millions
Addus Homecare Corp  10.23 $ 1,475.610  Millions$ 144.195  Millions
Dariohealth Corp   10.23 $ 21.196  Millions$ 2.072  Millions
Radnet Inc   10.11 $ 2,268.932  Millions$ 224.447  Millions
Utah Medical Products Inc  9.88 $ 35.679  Millions$ 3.612  Millions
Lensar Inc   9.75 $ 60.264  Millions$ 6.184  Millions
Biolife Solutions Inc   9.67 $ 102.718  Millions$ 10.626  Millions
Encompass Health Corporation  9.57 $ 6,206.100  Millions$ 648.325  Millions
The Oncology Institute Inc   9.57 $ 587.244  Millions$ 61.364  Millions
Alumis inc   9.44 $ 7.398  Millions$ 0.784  Millions
Enanta Pharmaceuticals Inc  9.29 $ 65.258  Millions$ 7.027  Millions
Neuronetics Inc   9.24 $ 154.594  Millions$ 16.732  Millions
Harmony Biosciences Holdings inc   9.22 $ 960.191  Millions$ 104.164  Millions

Date modified: 2026-09-08T15:11:45+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.